These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 25764049

  • 1. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population.
    Porthan K, Niiranen TJ, Varis J, Kantola I, Karanko H, Kähönen M, Nieminen MS, Salomaa V, Huikuri HV, Jula AM.
    J Hypertens; 2015 Jun; 33(6):1284-90. PubMed ID: 25764049
    [Abstract] [Full Text] [Related]

  • 2. Obesity and ECG left ventricular hypertrophy.
    Muiesan ML, Salvetti M, Di Castelnuovo A, Paini A, Assanelli D, Costanzo S, Badilini F, Vaglio M, Donati MB, Agabiti Rosei E, de Gaetano G, Iacoviello L, Moli-sani Study Investigators.
    J Hypertens; 2017 Jan; 35(1):162-169. PubMed ID: 27662187
    [Abstract] [Full Text] [Related]

  • 3. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN, Devereux RB, Okin PM.
    J Electrocardiol; 2014 Jan; 47(5):630-5. PubMed ID: 25052475
    [Abstract] [Full Text] [Related]

  • 4. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlöf B, LIFE Study Investigators.
    JAMA; 2004 Nov 17; 292(19):2343-9. PubMed ID: 15547161
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension.
    Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES.
    Am Heart J; 2010 May 17; 159(5):833-40. PubMed ID: 20435193
    [Abstract] [Full Text] [Related]

  • 6. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM, Visseren FLJ, Vernooij JWP, Nathoe HM, Cramer MM, Bemelmans RHH, van der Graaf Y, Spiering W, SMART-study group.
    J Hypertens; 2018 Sep 17; 36(9):1865-1873. PubMed ID: 29878973
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men?
    Antikainen RL, Grodzicki T, Palmer AJ, Beevers DG, Webster J, Bulpitt CJ, Department of Health and Social Security Hypertension Care Computer Project (DHCCP).
    J Hum Hypertens; 2006 Jun 17; 20(6):451-9. PubMed ID: 16708082
    [Abstract] [Full Text] [Related]

  • 10. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D, Chrysohoou C, Oikonomou E, Lazaros G, Dimitriadis K, Maragiannis D, Roussos D, Andreou I, Tsantilas A, Christoforatou E, Pitsavos C, Panagiotakos D, Stefanadis C.
    J Hypertens; 2011 Aug 17; 29(8):1624-32. PubMed ID: 21610511
    [Abstract] [Full Text] [Related]

  • 11. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.
    Cuspidi C, Facchetti R, Bombelli M, Sala C, Grassi G, Mancia G.
    J Hypertens; 2014 Apr 17; 32(4):921-8. PubMed ID: 24406778
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of left ventricular hypertrophy by different electrocardiographic criteria in clinical practice. Findings from the Sara study.
    Calderón A, Barrios V, Escobar C, Ferrer E, Barrios S, González-Pedel V, Montoro P, Navarro-Cid J.
    Clin Exp Hypertens; 2010 May 17; 32(3):145-53. PubMed ID: 20504121
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Gattobigio R, Zampi I, Porcellati C.
    J Am Coll Cardiol; 1998 Feb 17; 31(2):383-90. PubMed ID: 9462583
    [Abstract] [Full Text] [Related]

  • 15. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM, Hille DA, Kjeldsen SE, Devereux RB.
    J Am Heart Assoc; 2017 Nov 18; 6(11):. PubMed ID: 29151037
    [Abstract] [Full Text] [Related]

  • 16. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
    Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Dahlof B, Losartan Intervention for Endpoint reduction in hypertension Study Investigations.
    Circulation; 2003 Aug 12; 108(6):684-90. PubMed ID: 12885747
    [Abstract] [Full Text] [Related]

  • 17. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 18. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Jan 17; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 19. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R, Light RP.
    Clin J Am Soc Nephrol; 2011 Mar 17; 6(3):528-36. PubMed ID: 21088286
    [Abstract] [Full Text] [Related]

  • 20. Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
    Larstorp AC, Okin PM, Devereux RB, Olsen MH, Ibsen H, Dahlöf B, Kjeldsen SE, Wachtell K.
    J Hum Hypertens; 2011 Mar 17; 25(3):178-85. PubMed ID: 20505749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.